Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The two-pore domain potassium channel subfamily K member 3, commonly known as TASK-3 or KCNK3, is a leak potassium channel that sets the resting membrane potential in neurons and other cells by increasing potassium permeability, thereby hyperpolarizing the membrane and modulating excitability. It belongs to the K2P family of two-pore domain channels, which exhibit outward rectification and are active across a wide range of membrane potentials without voltage-gating or inactivation. TASK-3 is highly expressed in cerebellar granule neurons, hippocampus, thalamus, and other brain regions, where it supports sustained high-frequency action potential firing by reducing sodium channel inactivation and enhancing input conductance during depolarization. In TASK-3 knockout models, neurons show depolarized resting potentials, reduced leak conductance, and pronounced action potential accommodation, leading to firing failure during sustained stimuli. It forms homodimers or heterodimers with TASK-1, contributing to baseline potassium currents sensitive to pH and other modulators. While not directly linked to specific diseases in the sources, TASK-3 influences neuronal excitability relevant to processes like anesthesia response, as K2P channels including TASK-3 mediate hypnosis and immobilization effects. No approved drugs directly target TASK-3, but its role in background conductance positions it as a potential modulator of neuronal hyperactivity or related disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Two-pore domain potassium channel subfamily K member 3 (TASK-3) (KCNK3).